Agreement between ophthalmologists and optometrists in the certification of vision impairment
Sign Up to like & getrecommendations! Published in 2020 at "Eye"
DOI: 10.1038/s41433-020-0860-x
Abstract: Background/objectives The certification process to register patients as sight impaired or severely sight impaired is undertaken by consultant ophthalmologists, in the UK. We sought to assess the agreement between optometrists and a consensus panel, in… read more here.
Keywords: agreement; consensus panel; vision; ophthalmologists optometrists ... See more keywords
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients.
Sign Up to like & getrecommendations! Published in 2023 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2023.03.003
Abstract: The consensus panel 2 (CP2) of the 11th International Workshop on Waldenström's macroglobulinemia (IWWM-11) has reviewed and incorporated current data to update the recommendations for treatment approaches in patients with relapsed or refractory WM (RRWM).… read more here.
Keywords: consensus panel; international workshop; waldenstr macroglobulinemia; workshop waldenstr ... See more keywords
Report of consensus panel 1 from the 11th International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients.
Sign Up to like & getrecommendations! Published in 2023 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2023.03.005
Abstract: Consensus Panel 1 (CP1) of the 11th International Workshop on Waldenstrom's Macroglobulinemia (IWWM-11) was tasked with updating guidelines for the management of symptomatic, treatment-naïve patients with WM. The panel reiterated that watchful waiting remains the… read more here.
Keywords: consensus panel; treatment patients; 11th international; symptomatic treatment ... See more keywords
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trials.
Sign Up to like & getrecommendations! Published in 2023 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2023.03.006
Abstract: Recent advances in the understanding of Waldenström macroglobulinemia (WM) biology have impacted the development of effective novel agents and improved our knowledge of how the genomic background of WM may influence selection of therapy. Consensus… read more here.
Keywords: consensus panel; international workshop; clinical trials; waldenstr macroglobulinemia ... See more keywords
Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
Sign Up to like & getrecommendations! Published in 2023 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2023.03.007
Abstract: Apart from the MYD88L265P mutation, extensive information exists on the molecular mechanisms in Waldenström's Macroglobulinemia and its potential utility in the diagnosis and treatment tailoring. However, no consensus recommendations are yet available. Consensus Panel 3… read more here.
Keywords: consensus panel; waldenstr macroglobulinemia; waldenstr; diagnosis ... See more keywords